Bombermanx1
FULL MEMBER
- Joined
- Dec 19, 2013
- Messages
- 1,576
- Reaction score
- -12
- Country
- Location
That's true and they conduct stage 3 clinical trials in developing countries since no takers for clinical trials in west and europe, but will sell it high priced when the drug is proven effective.I think India govt should ask these pharma companies either decrease the cost according to the income of the patients or ask the companies to leave India. I know these monoclonal antibodies takes a lot of money to develop, but not in the range of 2-3 lakh. this is simply robbing the patient.pharma companies have a mean profit range of 500-600 percent.
what say @halupridol
Why is novartis and other companies investing big in India? and clinical research?
They get sufficient money to cover the cost of everything they did 3 times over if they sold normally, but these drugs are priced 30-40 times over. Now tell me is it profit or outright looting a person afflicted with disease ?The trouble is that if the money incentive did not exist, then nobody would do the research needed to invent new medicines. It's not a clear cut issue, there are ethical questions on both sides of the argument.
Last edited: